Name
SS8-02: New Drug Approvals for HR+ Metastatic Breast: Imlunestrant (INLURIYO) - Commentary By: Ruth O'Regan, MD
Date & Time
Wednesday, December 3, 2025
Speakers
Virtual Session Link
Total Minutes
04:59
OnDemand Video URL